Lainie Martin

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. pmc Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours
    L P Martin
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Br J Cancer 107:1268-76. 2012
  2. ncbi request reprint Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects
    Lainie Martin
    From Fox Chase Cancer Center, Philadelphia, Pennsylvania, PA 19103, USA
    J Natl Compr Canc Netw 4:955-66. 2006
  3. pmc Development of a syngeneic mouse model of epithelial ovarian cancer
    Bridget A Quinn
    Women s Cancer Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 2497, USA
    J Ovarian Res 3:24. 2010
  4. ncbi request reprint Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition
    Lainie Martin
    Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    J Clin Oncol 25:2894-901. 2007

Collaborators

Detail Information

Publications4

  1. pmc Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours
    L P Martin
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Br J Cancer 107:1268-76. 2012
    ..This phase I study investigated the safety, tolerability, pharmacokinetics and antitumour activity of axitinib combined with chemotherapy...
  2. ncbi request reprint Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects
    Lainie Martin
    From Fox Chase Cancer Center, Philadelphia, Pennsylvania, PA 19103, USA
    J Natl Compr Canc Netw 4:955-66. 2006
    ..This article reviews novel non-cytotoxic agents that target these pathways and are currently being evaluated in ovarian carcinoma treatment...
  3. pmc Development of a syngeneic mouse model of epithelial ovarian cancer
    Bridget A Quinn
    Women s Cancer Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 2497, USA
    J Ovarian Res 3:24. 2010
    ..The objective of this study was to establish an immunocompetent syngeneic mouse model of disseminated epithelial ovarian cancer (EOC) to facilitate laboratory-based studies of ovarian tumor biology and preclinical therapeutic strategies...
  4. ncbi request reprint Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition
    Lainie Martin
    Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    J Clin Oncol 25:2894-901. 2007
    ..Current data regarding the role of bevacizumab and other novel agents in the treatment of ovarian carcinoma are summarized...